Developer docs
API playgroundTry for free, no card

Search company profiles

Meatable

Full company profile

uuid0000qh4

Namestring
Meatable
Legal namestring
Meatable B.V.
Websiteurl
meatable.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Meatable B.V. was a Dutch cultivated meat company founded in 2018 in Delft (later headquartered in Leiden), developing slaughter-free meat products from pluripotent stem cells. Its core technology platform combined the opti-ox cell-differentiation process — in-licensed from bit.bio and claimed to produce mature muscle and fat cells in approximately four days at 100% efficiency — with the non-GMO mRNA reprogramming and saRNA differentiation platform acquired from Uncommon Bio in August 2025. The company produced cultivated pork sausages and dumplings and had begun cultivated beef development, while pursuing a multi-species capability across pork, chicken, lamb, and beef.

The company's business model was an asset-light, pure licensing structure in which traditional meat-industry partners would acquire territory-specific rights and produce under Meatable's process design, with royalties reinvested into technology optimization. Meatable did not plan to build its own production facilities or compete with its partners; instead it positioned itself as a technology vendor. Planned distribution hubs included Singapore (with ESCO Aster and TruMeat), Thailand (with Betagro), and eventual US and EU entry. Pricing was not publicly disclosed and the company was pre-commercial at the time of shutdown.

Meatable raised approximately €97 million across pre-seed, seed, Series A, Series B, and grant funding, with a €7.6M RVO Innovation Credit and a €30M Desmos Capital Partners placement as additional capital instruments. Key institutional backers included Agronomics, Invest-NL, BlueYard Capital, DSM Venturing, Betagro Ventures, and Desmos Capital Partners. Despite TIME Best Inventions 2024 recognition, a Tech Tour Growth50 2025 listing, and AgTech Breakthrough 2025 award, the company announced orderly dissolution and liquidation in December 2025 after failing to secure sufficient additional funding to continue operations beyond 2026.

Short descriptiontext

Meatable was a Dutch cultivated meat company (founded 2018, Leiden) that used opti-ox stem-cell technology to produce slaughter-free pork and beef, licensing its process to traditional meat-industry partners through an asset-light model. The company ceased operations in December 2025 after failing to secure continued funding.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLeiden, Netherlands
HQ citystring
Leiden
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cultivated meat production, cellular agriculture technology, stem cell technology, alternative protein licensing, lab-grown meat
Industry4 codes
PRIMARYAFANAKAC
Cultivated Meat Producers (Cell-Cultured Meat & Seafood)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SECONDARYAFAKAGAI
Cultivated (Cell-Based) Protein Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYAFANAKAF
Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SECONDARYAFANAKAO
Finished Meat-Alternative Prepared Foods (Nuggets, Burgers, Sausages, Ready Meals)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
NAICS code1 code
  • Animal Slaughtering and Processing3116
SIC code3 codes
  • Sausages & Other Prepared Meat Products2013
  • Meat Packing Plants2011
  • Food And Kindred Products2000
Product category
Cultivated Meat Technology
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Technology Licensing
TypeLicensing Royalties
Description

Licensing model where Meatable technology is licensed to meat industry partners who acquire specific territory rights. Royalties are reinvested into rapidly optimizing and diversifying technology, not assets. Provides near-term and ongoing revenues through licensing with high margins.

meatable.com
2Asset-Light Partnership Model
TypeLicensing Royalties
Description

Pure licensing model - no plant capex, no stranded/outdated assets. Funds only invested in tech optimization. Partners receive full process design, approved sourcing partners, product formulation help, consumer studies, and tech transfer support.

meatable.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Meatable produces cultivated (cell-grown) real meat using proprietary opti-ox stem cell technology, differentiating pluripotent stem cells into muscle and fat cells in approximately four days. The company sells its technology through an asset-light licensing model to traditional meat industry partners who acquire territory-specific rights, receiving full process design, approved sourcing partners, product formulation, and tech transfer support. Physical cultivated meat products (pork sausages, dumplings, beef) were also produced and showcased via tasting events.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 75% lower GHG emissions compared to traditional livestock farming
+5 more records
Product overview1 text field

Meatable operates as a cultivated meat technology company offering its opti-ox technology platform to the meat industry through an asset-light licensing model. The core offering includes cultivated pork products (sausages, dumplings) and beef, all produced using proprietary opti-ox technology that differentiates pluripotent stem cells into muscle and fat cells in approximately four days. The company has expanded its platform capabilities through the acquisition of Uncommon Bio's cultivated meat platform, adding non-GMO mRNA and saRNA technologies for multi-species product development. Meatable positions itself as a partner to traditional meat companies rather than a competitor, providing technology licensing and process design services.

Product and service4 records
1opti-ox Technology Platform
CategoryCore technology platform
Description

Proprietary stem cell technology platform that enables rapid differentiation of pluripotent stem cells into muscle and fat cells at 100% efficiency in approximately four days. Licensed to meat industry partners through an asset-light model with full process design, approved sourcing partners, product formulation support, and tech transfer services.

2Cultivated Pork Sausages
CategoryCultivated meat product
Description

Slaughter-free pork sausages produced from cultivated muscle and fat cells using opti-ox technology, achieving taste and texture comparable to traditional pork. Featured at tasting events for chefs and food service operators in Singapore and Europe.

3Cultivated Pork Dumplings
CategoryCultivated meat product
Description

Products incorporating cultivated pork cells for use in dumplings and other ground meat applications, produced using opti-ox technology. Targeted at restaurants and food service operators in Singapore and other launch markets.

4Cultivated Beef
CategoryCultivated meat product
Description

Cultivated beef products developed using the same opti-ox technology platform, expanding the product portfolio beyond pork as part of Meatable's multi-species protein strategy.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-21
Description

Acquisition of Uncommon Bio's cultivated meat platform including key technology, IP assets, high-performing cell lines, and expert staff. Uncommon Bio pivoted to therapeutics.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Collaboration to optimize cell feed preparation, reducing preparation time from several days to just 30 minutes. Integration of food-grade ingredients tailored for cell culture applications.

3TruMeat
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-30
Description

Strategic collaboration for commercial-scale cultivated meat facility in Singapore. TruMeat specializes in contract manufacturing of cultivated meat at commercial scale using continuous process, modular and fully automated technology. Focus on optimizing processes and media development.

meatable.com
Strategic tierMinorTypeOthersAnnounced on2025-04-22
Description

Earth Day partnership - Meatable supporting mission-driven organization focused on sustainable food systems research and advocacy.

Strategic tierMinorTypeOthersAnnounced on2025-04-22
Description

Meatable joined UN Global Compact, aligning strategies with universal principles on environment, human rights, and labor while contributing to Sustainable Development Goals.

Strategic tierMinorTypeOthersAnnounced on2025-04-22
Description

Earth Day partnership supporting global nonprofit committed to ending world hunger by partnering with communities to achieve sustainable futures.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-02-11
Description

Collaboration for sustainable leather technology. Meatable's opti-ox technology being explored to enhance Pelagen's production of skin tissue from animal cells for animal-free leather.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-10-15
Description

GFI-funded research collaboration to develop a precise genome-scale metabolic model of porcine cells to increase yield and reduce process variability.

9Love Handle
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-11-16
Description

Partnership to create world's first hybrid meat innovation center in Singapore. Combined cultivated meat with plant-based products.

meatable.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-10
Description

Partnership to become first cultivated pork manufacturer in Singapore. ESCO Aster is the world's only licensed cultivated meat manufacturer in Singapore.

11Royal DSM
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-09-13
Description

Joint Development Agreement to develop affordable growth media for cultivated meat. Partnership to reduce production costs and improve scalability.

meatable.com
Strategic tierCoreTypeTechnology or Integration
Description

In-licensing partner for opti-ox technology - patented technology enabling rapid cell differentiation from pluripotent stem cells at 100% efficiency.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Israeli cultivated meat company growing whole-cut beef steaks from animal cells. Direct peer in cultivated red meat, with similar technology stack, regulatory pathway challenges, and B2B partnerships with meat industry players and food service.

TypeDirect peer
Description

Dutch cultivated beef pioneer founded in 2013 and the most direct geographic and technological peer to Meatable, also developing cell-cultured meat from animal stem cells without slaughter. Both companies pursued the EU regulatory pathway and targeted partnerships with traditional meat companies.

TypeBroad incumbent
Description

Largest publicly-traded plant-based meat alternative company. A broader incumbent in the alternative protein space, serving similar retail and food service customers but with plant-based rather than cultivated technology. Useful comparable for retail penetration, food service partnerships, and alternative protein consumer dynamics.

TypeDirect peer
Description

Israeli cultivated chicken company with a strong focus on the Singapore market and partnership-driven commercialization. Direct peer in cultivated meat with similar technology approach and Asian market entry strategy.

TypeDirect peer
Description

Cultivated meat division of Eat Just, focused on cell-cultured chicken — the first company to receive regulatory approval for cultivated meat in Singapore. Most directly comparable to Meatable on Singapore-first commercialization, regulatory pathway, and cultivated meat positioning.

TypeBroad incumbent
Description

Major plant-based meat alternative company with strong food service and retail presence. Comparable to Meatable as a competing alternative protein approach targeting meat-industry replacement, with similar sustainability narrative and B2B commercialization model.

TypeDirect peer
Description

US-based cultivated meat company producing cell-cultured chicken, beef, and duck using stem cell biology. A direct competitor in the cultivated meat category with similar technology, regulatory pathway, and B2B commercialization approach via restaurants and retail partners.

TypeEmerging player
Description

US-based company producing cultivated salmon from fish cells. Comparable technology stack (cell-based animal protein without slaughter) with partial overlap — focused on seafood rather than terrestrial meat, and the only cultivated seafood company with US FDA acceptance.

9Shiok Meats
TypeEmerging player
Description

Singapore-based cultivated seafood company producing cell-cultured shrimp, crab, and lobster. Comparable to Meatable in Singapore-first commercialization and Asia-Pacific market focus, but specializes in crustacean protein.

TypeDirect peer
Description

Israeli cultivated meat company focused on cost-efficient production of cell-cultured chicken, beef, and lamb. Comparable to Meatable in pursuing technology-driven cost reduction and scaling strategies for cultivated protein.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Meatable

Cultivated Meat Technologymeatable.com

Meatable was a Dutch cultivated meat company (founded 2018, Leiden) that used opti-ox stem-cell technology to produce slaughter-free pork and beef, licensing its process to traditional meat-industry partners through an asset-light model. The company ceased operations in December 2025 after failing to secure continued funding.

What Meatable does

Meatable B.V. was a Dutch cultivated meat company founded in 2018 in Delft (later headquartered in Leiden), developing slaughter-free meat products from pluripotent stem cells. Its core technology platform combined the opti-ox cell-differentiation process — in-licensed from bit.bio and claimed to produce mature muscle and fat cells in approximately four days at 100% efficiency — with the non-GMO mRNA reprogramming and saRNA differentiation platform acquired from Uncommon Bio in August 2025. The company produced cultivated pork sausages and dumplings and had begun cultivated beef development, while pursuing a multi-species capability across pork, chicken, lamb, and beef.

The company's business model was an asset-light, pure licensing structure in which traditional meat-industry partners would acquire territory-specific rights and produce under Meatable's process design, with royalties reinvested into technology optimization. Meatable did not plan to build its own production facilities or compete with its partners; instead it positioned itself as a technology vendor. Planned distribution hubs included Singapore (with ESCO Aster and TruMeat), Thailand (with Betagro), and eventual US and EU entry. Pricing was not publicly disclosed and the company was pre-commercial at the time of shutdown.

Meatable raised approximately €97 million across pre-seed, seed, Series A, Series B, and grant funding, with a €7.6M RVO Innovation Credit and a €30M Desmos Capital Partners placement as additional capital instruments. Key institutional backers included Agronomics, Invest-NL, BlueYard Capital, DSM Venturing, Betagro Ventures, and Desmos Capital Partners. Despite TIME Best Inventions 2024 recognition, a Tech Tour Growth50 2025 listing, and AgTech Breakthrough 2025 award, the company announced orderly dissolution and liquidation in December 2025 after failing to secure sufficient additional funding to continue operations beyond 2026.

Meatable firmographics

Firmographics
Name
Meatable
Legal name
Meatable B.V.
Website
https://meatable.com
Company type
Private
Founded year
2018
Operating status
Closed
Headcount range
51–100 employees
Short description
Meatable was a Dutch cultivated meat company (founded 2018, Leiden) that used opti-ox stem-cell technology to produce slaughter-free pork and beef, licensing its process to traditional meat-industry partners through an asset-light model. The company ceased operations in December 2025 after failing to secure continued funding.
Ownership category
akta.pro rank

Meatable industry classification

Industry
Product category
Cultivated Meat Technology
NAICS
Animal Slaughtering and Processing (3116)
SIC
Sausages & Other Prepared Meat Products (2013), Meat Packing Plants (2011), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFANAKAC
Cultivated Meat Producers (Cell-Cultured Meat & Seafood)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SECONDARYAFAKAGAI
Cultivated (Cell-Based) Protein Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYAFANAKAF
Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SECONDARYAFANAKAO
Finished Meat-Alternative Prepared Foods (Nuggets, Burgers, Sausages, Ready Meals)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)

Keywords

  • Cultivated meat production
  • Cellular agriculture technology
  • Stem cell technology
  • Alternative protein licensing
  • Lab-grown meat

Where Meatable is headquartered

Location

Headquarters

HQ city
Leiden
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

Meatable business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Technology Licensing: Licensing model where Meatable technology is licensed to meat industry partners who acquire specific territory rights. Royalties are reinvested into rapidly optimizing and diversifying technology, not assets. Provides near-term and ongoing revenues through licensing with high margins.
  2. Asset-Light Partnership Model: Pure licensing model - no plant capex, no stranded/outdated assets. Funds only invested in tech optimization. Partners receive full process design, approved sourcing partners, product formulation help, consumer studies, and tech transfer support.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Meatable product offering

Product offering

Core offering

Meatable produces cultivated (cell-grown) real meat using proprietary opti-ox stem cell technology, differentiating pluripotent stem cells into muscle and fat cells in approximately four days. The company sells its technology through an asset-light licensing model to traditional meat industry partners who acquire territory-specific rights, receiving full process design, approved sourcing partners, product formulation, and tech transfer support. Physical cultivated meat products (pork sausages, dumplings, beef) were also produced and showcased via tasting events.

Product overview

Meatable operates as a cultivated meat technology company offering its opti-ox technology platform to the meat industry through an asset-light licensing model. The core offering includes cultivated pork products (sausages, dumplings) and beef, all produced using proprietary opti-ox technology that differentiates pluripotent stem cells into muscle and fat cells in approximately four days. The company has expanded its platform capabilities through the acquisition of Uncommon Bio's cultivated meat platform, adding non-GMO mRNA and saRNA technologies for multi-species product development. Meatable positions itself as a partner to traditional meat companies rather than a competitor, providing technology licensing and process design services.

Differentiator

Problem solved

Functional benefit

Products and services

  • opti-ox Technology Platform Proprietary stem cell technology platform that enables rapid differentiation of pluripotent stem cells into muscle and fat cells at 100% efficiency in approximately four days. Licensed to meat industry partners through an asset-light model with full process design, approved sourcing partners, product formulation support, and tech transfer services.
  • Cultivated Pork Sausages Slaughter-free pork sausages produced from cultivated muscle and fat cells using opti-ox technology, achieving taste and texture comparable to traditional pork. Featured at tasting events for chefs and food service operators in Singapore and Europe.
  • Cultivated Pork Dumplings Products incorporating cultivated pork cells for use in dumplings and other ground meat applications, produced using opti-ox technology. Targeted at restaurants and food service operators in Singapore and other launch markets.
  • Cultivated Beef Cultivated beef products developed using the same opti-ox technology platform, expanding the product portfolio beyond pork as part of Meatable's multi-species protein strategy.

Quantifiable outcome

  • 75% lower GHG emissions compared to traditional livestock farming
  • +5 more outcomes

Companies that use Meatable

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Meatable technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Meatable partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • Uncommon BiocoreStrategic or Co-development Partner · 21 August 2025Acquisition of Uncommon Bio's cultivated meat platform including key technology, IP assets, high-performing cell lines, and expert staff. Uncommon Bio pivoted to therapeutics.
  • NutrecominorStrategic or Co-development Partner · 21 May 2025Collaboration to optimize cell feed preparation, reducing preparation time from several days to just 30 minutes. Integration of food-grade ingredients tailored for cell culture applications.
  • TruMeatcoreStrategic or Co-development Partner · 30 April 2025Strategic collaboration for commercial-scale cultivated meat facility in Singapore. TruMeat specializes in contract manufacturing of cultivated meat at commercial scale using continuous process, modular and fully automated technology. Focus on optimizing processes and media development.
  • Food TankminorOthers · 22 April 2025Earth Day partnership - Meatable supporting mission-driven organization focused on sustainable food systems research and advocacy.
  • United Nations Global CompactminorOthers · 22 April 2025Meatable joined UN Global Compact, aligning strategies with universal principles on environment, human rights, and labor while contributing to Sustainable Development Goals.
  • The Hunger ProjectminorOthers · 22 April 2025Earth Day partnership supporting global nonprofit committed to ending world hunger by partnering with communities to achieve sustainable futures.
  • PelagenminorStrategic or Co-development Partner · 11 February 2025Collaboration for sustainable leather technology. Meatable's opti-ox technology being explored to enhance Pelagen's production of skin tissue from animal cells for animal-free leather.
  • Sticta BiologicalsminorStrategic or Co-development Partner · 15 October 2024GFI-funded research collaboration to develop a precise genome-scale metabolic model of porcine cells to increase yield and reduce process variability.
  • Love HandleminorStrategic or Co-development Partner · 16 November 2022Partnership to create world's first hybrid meat innovation center in Singapore. Combined cultivated meat with plant-based products.
  • ESCO AstercoreStrategic or Co-development Partner · 10 October 2022Partnership to become first cultivated pork manufacturer in Singapore. ESCO Aster is the world's only licensed cultivated meat manufacturer in Singapore.
  • Royal DSMcoreStrategic or Co-development Partner · 13 September 2021Joint Development Agreement to develop affordable growth media for cultivated meat. Partnership to reduce production costs and improve scalability.
  • bit.biocoreTechnology or IntegrationIn-licensing partner for opti-ox technology - patented technology enabling rapid cell differentiation from pluripotent stem cells at 100% efficiency.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

Meatable competitors and assessment

Company assessment

Direct peers

  • Aleph Farms: Israeli cultivated meat company growing whole-cut beef steaks from animal cells. Direct peer in cultivated red meat, with similar technology stack, regulatory pathway challenges, and B2B partnerships with meat industry players and food service.
  • Mosa Meat: Dutch cultivated beef pioneer founded in 2013 and the most direct geographic and technological peer to Meatable, also developing cell-cultured meat from animal stem cells without slaughter. Both companies pursued the EU regulatory pathway and targeted partnerships with traditional meat companies.
  • SuperMeat: Israeli cultivated chicken company with a strong focus on the Singapore market and partnership-driven commercialization. Direct peer in cultivated meat with similar technology approach and Asian market entry strategy.
  • GOOD Meat (Eat Just): Cultivated meat division of Eat Just, focused on cell-cultured chicken — the first company to receive regulatory approval for cultivated meat in Singapore. Most directly comparable to Meatable on Singapore-first commercialization, regulatory pathway, and cultivated meat positioning.
  • Upside Foods: US-based cultivated meat company producing cell-cultured chicken, beef, and duck using stem cell biology. A direct competitor in the cultivated meat category with similar technology, regulatory pathway, and B2B commercialization approach via restaurants and retail partners.
  • Future Meat Technologies: Israeli cultivated meat company focused on cost-efficient production of cell-cultured chicken, beef, and lamb. Comparable to Meatable in pursuing technology-driven cost reduction and scaling strategies for cultivated protein.

Broad incumbents

  • Beyond Meat: Largest publicly-traded plant-based meat alternative company. A broader incumbent in the alternative protein space, serving similar retail and food service customers but with plant-based rather than cultivated technology. Useful comparable for retail penetration, food service partnerships, and alternative protein consumer dynamics.
  • Impossible Foods: Major plant-based meat alternative company with strong food service and retail presence. Comparable to Meatable as a competing alternative protein approach targeting meat-industry replacement, with similar sustainability narrative and B2B commercialization model.

Emerging players

  • Wildtype: US-based company producing cultivated salmon from fish cells. Comparable technology stack (cell-based animal protein without slaughter) with partial overlap — focused on seafood rather than terrestrial meat, and the only cultivated seafood company with US FDA acceptance.
  • Shiok Meats: Singapore-based cultivated seafood company producing cell-cultured shrimp, crab, and lobster. Comparable to Meatable in Singapore-first commercialization and Asia-Pacific market focus, but specializes in crustacean protein.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Meatable social profiles

Digital presence

Meatable financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Meatable leadership team

Management profile

Number of profiles

Profiles10 records

Meatable subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Meatable funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Meatable M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meatable

What does Meatable do?

Meatable produces cultivated (cell-grown) real meat using proprietary opti-ox stem cell technology, differentiating pluripotent stem cells into muscle and fat cells in approximately four days. The company sells its technology through an asset-light licensing model to traditional meat industry partners who acquire territory-specific rights, receiving full process design, approved sourcing partners, product formulation, and tech transfer support. Physical cultivated meat products (pork sausages, dumplings, beef) were also produced and showcased via tasting events.

Is Meatable a public or private company?

Meatable is a private company. It is classified as venture growth investor backed and is currently closed.

When was Meatable founded?

Meatable was founded in 2018. It employs 51 to 100 people.

Where is Meatable based?

Meatable is headquartered in Leiden, Netherlands, in the Europe region.

How does Meatable make money?

Two revenue lines are on record. Technology Licensing is the primary driver. The others are asset-Light Partnership Model.

Who are Meatable's main competitors?

Direct peers on record are Aleph Farms, Mosa Meat, SuperMeat, GOOD Meat (Eat Just), Upside Foods and Future Meat Technologies. Broad incumbents are Beyond Meat and Impossible Foods. Emerging players are Wildtype and Shiok Meats.

Does Meatable have an API?

No public API is recorded for Meatable.

What industry is Meatable in?

Meatable's product category is Cultivated Meat Technology. Its primary akta.pro industry code is AFANAKAC, Cultivated Meat Producers (Cell-Cultured Meat & Seafood), with a secondary code of AFAKAGAI, Cultivated (Cell-Based) Protein Foods Manufacturing. Its NAICS code is 3116 and its SIC code is 2013.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Cool DownCultivated meat barely left the gate, and two of its best-funded startups are already goneInvestment in cultivated meat has collapsed from $989 million in 2021 to just $82.6 million in 2025, with Believer Meats and Meatable—two of the sector's top fundraisers—closing operations in December 2024, while Good Meat and Upside Foods face ongoing production challenges. Industry experts now argue that regulatory approvals alone are insufficient and that the sector must demonstrate commercial viability through paid partnerships and real offtake agreements. Analysts suggest high-end seafood products like cultivated bluefin tuna, exemplified by BlueNalu, may be the most viable near-term path to market due to pricing dynamics favouring premium specialty cuts.AgFunderNewsCultivated meat deep dive: After the crash, who’s still standing?The cultivated meat industry is facing a severe funding crisis, with investment plummeting from $989 million in 2021 to $82.6 million in 2025, and major players including Believer Meats and Meatable ceasing operations in December while GOOD Meat struggles with profitable production scale-up. Despite the financial collapse, surviving companies are pursuing diverse strategies including focusing on high-value products in supply-constrained markets such as bluefin tuna, pursuing consolidation through facility acquisitions like UPSIDE Foods' $50 million bid for Believer Meats' North Carolina facility, and some pivoting toward life sciences applications. Technical advances continue across cell line development, bioprocessing, and food-grade inputs, but experts say commercial viability requires cost parity with conventional meat and the sector may see further consolidation as capital remains scarce.New Market PitchTop Alternative Protein Startups by Fundraising (2026)This article presents a comprehensive ranking of 88 alternative protein startups by total cumulative funding raised, with Perfect Day ($800M), UPSIDE Foods ($583M), and LIVEKINDLY Collective ($535M) occupying the top positions. Key market insights reveal that cultivated meat startups Believer Meats and Meatable both shut down in late 2025 despite raising $363M and $95M respectively, while Mosa Meat is the only cultivated meat startup to successfully raise new equity in both 2024 and 2025. Among well-funded startups raising above $50M with strong or full confidence data, nine out of thirteen remain active as of March 2026, representing a 69% survival rate.Just FoodNew reality: cultivated meat recalibrates as funding pool shrinksThe cultivated meat industry is undergoing a funding downturn and consolidation phase, with companies like Dutch firm Meatable and Israel-founded Believer Meats shutting down less than a decade after launching. The sector faces significant challenges including regulatory hurdles, high production costs, and investor capital shifting toward AI, prompting surviving companies to seek partnerships with shared manufacturing hubs like The Cultured Hub to achieve scale. Despite the setbacks, some companies including Aleph Farms and Mosa Meat continue operations, with industry experts suggesting the current consolidation mirrors early automotive industry patterns where only a few players will ultimately succeed.Electronic Payments InternationalEuropean tech investments: December signals that defined 2025December 2025 concluded a year of significant shifts in the European tech venture landscape, with FoodTech entering a rigorous selection phase where Meatable closed operations after failing to secure new funding while competitors like Mosa Meat (€15M) and Those Vegan Cowboys (€6.25M) continued attracting capital. AI moved into an execution phase with Agentic AI emerging through companies like PolyAI (€73M), Equixly (€10M), and Mirelo AI (€35M), while DeepTech developed institutional pipelines and non-dilutive financing scaled up with Reface securing a €15.2M revenue share deal. The article identifies five fundamental trends reshaping European venture markets: acceptance of financial engineering, growth of industrial tech, defense becoming a capital market, consolidation as system maintenance, and market polarization between top-tier and micro-seed activity.PlanetfoodWhy the U.S. Is Backing Meat & Dairy and Side-Lining Plant-Based Proteins?The new U.S. Dietary Guidelines have re-centered red meat and dairy as primary protein sources, effectively sidelining plant-based alternatives from a nutritional equivalence standpoint. Concurrently, the sector faces significant financial distress, evidenced by Meati Foods having its property seized for nearly $7 million in unpaid taxes following the shutdowns of competitors Believer Meats and Meatable.CounterpunchPrivate Cultivated-Meat Failures Reaffirm Need for Public ResearchTwo cultivated-meat companies, Believer Meats (formerly Future Meat Technologies) and Meatable, have shut down or begun winding down operations due to inability to secure funding or pay creditors. Believer Meats failed to pay over $34 million owed to a construction firm for a cellular-agriculture facility in North Carolina, despite having received FDA approval to sell cultivated chicken in the United States, while Dutch firm Meatable could not obtain necessary investment to proceed with building a commercial-scale cultivated pork factory in Singapore where regulatory approval was pending. The article argues these failures demonstrate that private investment alone cannot sustain cultivated-meat research, citing a significant drop in sector investment since 2021 and calling for hundreds of millions or billions in public funding to advance the science.MeatingplaceAs Cultivated Meat Firms Crumble, Warning Signs were Long ApparentBeliever Meats abruptly ceased operations on Dec. 10 after raising $347 million in Series B funding in 2021, followed weeks later by Meatable's closure after raising approximately $105 million, representing a significant collapse in the cultivated meat sector. Experts quoted in the article, including Ricardo San Martin of UC Berkeley and Julian Mellentin of New Nutrition Business, said they had warned for years that the industry's technological limitations—including expensive bioreactors, contamination risks, and an estimated production cost of at least $18 per pound for cultivated ground beef—were insurmountable. The article frames the cultivated meat collapse as 'one of the biggest failures in food industry history,' attributing it to investor irrational exuberance during zero-interest-rate years, consumer resistance to 'eating technology,' and a fundamental misunderstanding of food traditions and culture.EU-StartupsDutch cultivated meat startup Meatable to shut down operations after failing to secure fundingLeiden-based cultivated meat startup Meatable is winding down operations after failing to secure continued funding, with key stakeholder Agronomics announcing the closure on 19 December 2025. Agronomics, which had invested nearly €9 million in the company, is writing down its stake from a valuation of €13.6 million to zero. The startup had raised over €85.3 million in total funding, including a €29.8 million round led by Agronomics in 2023, and had recently acquired Uncommon Bio's cultivated meat platform while collaborating with TruMeat on a Singapore facility.